TABLE 3.
Univariate and multivariate cox regression analysis of overall survival.
| Characteristics | Univariate cox analysis | Multivariate cox analysis | ||
|---|---|---|---|---|
| Hazard ratio (95%CI) | p value | Hazard ratio (95%CI) | p value | |
| Age (year) | ||||
| ≤50 | Reference | Reference | ||
| >50 | 2.103 (1.199–3.689) | 0.010* | 1.770 (0.640–4.900) | 0.272 |
| BMI | ||||
| ≤23 | Reference | |||
| >23 | 0.810 (0.463–1.416) | 0.460 | ||
| Menstrual status | ||||
| Premenopausal | Reference | Reference | ||
| Postmenopausal | 1.859 (1.067–3.238) | 0.029* | 0.910 (0.320–2.570) | 0.852 |
| Histological grade a | ||||
| 1/2 | Reference | |||
| 3 | 1.235 (0.701–2.176) | 0.464 | ||
| Lymphovascular invasion | ||||
| No | Reference | Reference | ||
| Yes | 2.689 (1.504–4.809) | 0.001* | 1.820 (0.920–3.600) | 0.086 |
| Ki-67 index at diagnosis < 30% b | ||||
| No | Reference | |||
| Yes | 0.891 (0.456–1.740) | 0.735 | ||
| T stage c | ||||
| 1 | Reference | Reference | ||
| 2 | 0.880 (0.473–1.638) | 0.686 | 0.820 (0.430–1.540) | 0.535 |
| 3 | 1.363 (0.537–3.458) | 0.514 | 1.020 (0.370–2.870) | 0.963 |
| 4 | 5.251 (1.536–17.958) | 0.008* | 3.880 (1.070–13.990) | 0.039* |
| N stage c | ||||
| 0 | Reference | Reference | ||
| 1 | 2.099 (1.002–4.397) | 0.049* | 1.990 (0.930–4.280) | 0.077 |
| 2 | 3.640 (1.621–8.174) | 0.002* | 2.990 (1.260–7.060) | 0.013* |
| 3 | 7.134 (3.392–15.006) | <0.001* | 4.510 (1.940–10.500) | <0.001* |
| IronMLR score | ||||
| Low | Reference | Reference | ||
| High | 2.404 (1.201–4.808) | 0.013* | 2.730 (1.310–5.710) | 0.008* |
*p<0.05.
Histological grade at diagnosis was based on the degree of histological tumor differentiation.
The Ki-67 index at diagnosis indicates DNA synthetic activity as measured using immunocytochemistry.
Diagnosed based on the AJCC 2010 criteria (seventh edition).